SIM-0505

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameSIM-0505
Drug Alias NameSIM-0505
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Cadherin-6DNA topoisomerase I inhibitors
TargetsCadherin-6DNA topoisomerase I
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHainan Xiansheng Re Ming Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHainan Xiansheng Re Ming Pharmaceutical Co LtdShanghai Xiansheng Zaiming Pharmaceutical Biotechnology Co LtdNextcure Inc +[4] 
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A